Understanding Inlyta (Axitinib) Dosage for Advanced Kidney Cancer

Inlyta (Axitinib): A Detailed Look at Dosage for Advanced Kidney Cancer Inlyta, with the active ingredient axitinib, is a crucial prescription medication used in the treatment of advanced renal cell carcinoma (RCC), a form of kidney cancer that has spread or cannot be surgically removed. It belongs to a class of drugs known as kinase inhibitors, which work by targeting specific pathways involved in cancer cell growth. This article provides a comprehensive guide to Inlyta dosage, strengths, and how to take this medication, tailored for an Indian audience seeking clear and practical information. What is Inlyta and How Does it Work? Inlyta (axitinib) is designed to inhibit tyrosine kinases, enzymes that play a vital role in the growth and spread of cancer cells. By blocking these enzymes, Inlyta helps to slow down or stop the progression of advanced kidney cancer. It is available as an oral tablet and is typically taken twice daily. Inlyta Strengths and Forms Inlyta comes in two strengths: 1 mg and 5 mg oral tablets. The choice of strength and the dosage regimen are determined by your doctor based on your individual health status, response to treatment, and potential side effects. Standard Dosage for Advanced RCC The typical starting dosage for adults with advanced RCC is 5 mg of Inlyta taken twice per day , with doses administered approximately every 12 hours. It is important to adhere strictly to the prescribed schedule. Dosage Adjustments and Titration Your doctor will closely monitor your response to Inlyta and may adjust the dosage as needed. This process, known as dose titration, can involve increasing or decreasing the dose based on several factors: Increasing the Dose: If you are taking Inlyta alone and tolerate it well without significant side effects after about two weeks, your doctor might consider increasing the dosage. This could be a step-wise increase, for example, from 5 mg twice daily to 7 mg twice daily, and potentially further to 10 mg twice daily. The rate of increase may be slower if you have high blood pressure or are taking medication for it. Decreasing the Dose: If you experience bothersome or severe side effects, your doctor may reduce your Inlyta dose by half. In some cases, treatment may need to be paused or stopped altogether. Monitoring Response: Regular check-ups and tests are essential to assess how well the medication is working and to identify any potential issues early on. Inlyta in Combination Therapy Inlyta is often used in combination with other immunotherapy drugs for advanced RCC, particularly as a first-line treatment. The common combination therapies include: Inlyta with Avelumab (Bavencio): In this regimen, Inlyta is typically started at 5 mg twice daily. Avelumab is administered as an intravenous (IV) infusion of 800 mg over 60 minutes, once every two weeks. The dosage of Inlyta may be adjusted by the doctor after the initial two weeks or longer, based on your response and tolerance. Inlyta with Pembrolizumab (Keytruda): For this combination, Inlyta is also usually started at 5 mg twice daily. Pembrolizumab is given as an IV infusion over 30 minutes. The dosage is typically 200 mg every three weeks or 400 mg every six weeks. Similar to the avelumab combination, Inlyta dosage adjustments may be made by your doctor after six weeks or longer, depending on your treatment progress. It is crucial to understand that the specific dosages and schedules for combination therapies are complex and will be meticulously managed by your oncologist. Important Considerations for Taking Inlyta Follow these guidelines carefully when taking Inlyta: Administration: Inlyta comes as an oral tablet. Take it with a glass of water. Timing: Take the tablets approximately every 12 hours. With or Without Food: You can take Inlyta with or without food. Swallow Whole: Do not cut, crush, or chew the tablets. Swallow them whole to ensure the correct dose is delivered and absorbed. Missed Dose: If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Drug Interactions Inlyta can interact with other medications, potentially increasing the risk of side effects. Your doctor will review all the medications you are currently taking. Special attention is given to drugs that inhibit the enzyme CYP3A4/5, as these can increase the levels of Inlyta in your body. Examples include certain antifungal medications and some antibiotics. Your doctor may need to reduce your Inlyta dosage if you are taking such medications. Duration of Treatment Inlyta is generally considered a long-term treatment. If your doctor finds it safe and effective for your condition, you may continue taking it for an extended period. The decision to continue or stop treatment will be made collaboratively between you and your healthcare provider. When to Consult Your Doctor It is essential to stay in close communication with your doctor throughout your treatment with Inlyta. Consult your doctor immediately if you experience any of the following: Severe or Persistent Side Effects: Such as high blood pressure, fatigue, diarrhea, nausea, or voice changes. Signs of Bleeding: Unusual bruising, nosebleeds, blood in urine or stool, or coughing up blood. Signs of Blood Clots: Chest pain, shortness of breath, swelling or pain in a limb. Heart Problems: Changes in heart rate or rhythm. Liver

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.